LabCompass

Walter Hanel

Medicine · The Ohio State University

Established · publishing since 1968Rising activity

Publications

109

Citations

1,485

Est. group size

~42

Recurring co-author estimate

Active years

59

Publishing since 1968

Research summary
AI-generated

Walter Hanel's work focuses on lymphomas and related blood cancers, including Hodgkin lymphoma, non-Hodgkin lymphoma, mantle cell lymphoma, and rare T-cell lymphomas. His research includes clinical trials of new drug combinations, analyses of treatment outcomes and prognosis, and reviews summarizing evolving treatment options for these cancers. Much of the work is clinically oriented, drawing on patient outcome data and multi-center studies to inform how these blood cancers are managed.

Lymphoma treatment and outcomesHodgkin and non-Hodgkin lymphomaClinical trials for blood cancersStem cell/autologous transplantation in lymphomaRare T-cell lymphomas

Publication output has grown substantially over the last decade, rising from just 1 paper in 2017 to over a dozen per year since 2022, with a notable peak in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 15.0/year recently
2017: 1 publication17182019: 2 publications192020: 6 publications202021: 6 publications212022: 13 publications222023: 15 publications232024: 13 publications242025: 27 publications27252026: 7 publications26
Recent publications
Publishes in
  • Blood×22
  • Blood Advances×6
  • Transplantation and Cellular Therapy×5
  • Journal of Hematology & Oncology×4
  • Hematological Oncology×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile